VDA
VDA (Vascular Disrupting Agents) are compounds that specifically target and disrupt the existing blood vessels within tumors. Unlike traditional anti-angiogenic agents, which prevent the formation of new blood vessels, VDAs collapse the tumor's established vasculature, leading to tumor necrosis. VDAs are valuable in cancer therapy as they can effectively cut off the blood supply to tumors, resulting in rapid tumor shrinkage. At CymitQuimica, we offer a range of high-quality VDAs to support your research in oncology, vascular biology, and angiogenesis.
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Auristatin F REF: TM-T14349CAS: 163768-50-1 | 98% - 99.25% | 63.00 €~238.00 € | Wed 08 Jan 25 | |
Valecobulin hydrochloride REF: TM-T13278CAS: 1240321-53-2 | 98.63% | 87.00 €~1,063.00 € | Wed 05 Feb 25 |
Auristatin F
Ref: TM-T14349
5mg | 63.00 € | ||
10mg | 86.00 € | ||
25mg | 119.00 € | ||
50mg | 168.00 € | ||
100mg | 238.00 € |
Valecobulin hydrochloride
Ref: TM-T13278
1mg | 87.00 € | ||
5mg | 166.00 € | ||
10mg | 253.00 € | ||
25mg | 418.00 € | ||
50mg | 588.00 € | ||
100mg | 793.00 € | ||
200mg | 1,063.00 € | ||
1mL*10mM (DMSO) | 202.00 € |